ClinicalTrials.govpublic full text
Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma
melanoma, asci (antigen-specific cancer immunotherapeutic), mage-a3, malignant melanoma, cancer immunotherapeutic, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 831993
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.